Medical Research Director
Fenway Health
Boston, MA, United States
Dr. Mayer trained in Internal Medicine at Beth Israel Hospital and in Infectious Diseases at Brigham and Women’s Hospital. As the founding Medical Research Director of Fenway Health, he created a community health research program that has developed an international reputation for its capability to conduct community-based research, focusing on sexual and gender minority health and biobehavioral approaches to HIV and STI prevention. He is a Professor of Medicine at Harvard Medical School, a Professor in Global Health and Population at the Harvard TC Chan School of Public Health, and he is an Attending Physician at Beth Israel Deaconess Medical Center. Starting in 1994, he has been a site Principal Investigator of NIH-funded clinical trials units (HPTN, MTN, HVTN, ATN) focusing on bio-behavioral HIV prevention research, and is a member of the scientific leadership of HPTN. He has co-authored more than 1000 peer-reviewed publications, co-authored the first text on AIDS for the general public and has co-edited 5 academic texts. He has served on the governing boards of amfAR, HIVMA and IAS, CDC/HRSA HIV/AIDS Advisory Committee, the PEPFAR Scientific Advisory Board, and is an Editor-in-Chief of the Journal of the International AIDS Society.
Disclosure(s): Gilead Biosciences: Advisor/Consultant, Grant/Research Support; GSK/ViiV Healthcare: Advisor/Consultant, Grant/Research Support; Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support; Moderna, Inc.: Grant/Research Support
167 - Putting “PEP” to the Step: Doxycycline Post-Exposure Prophylaxis
Tuesday, October 21, 2025
1:45 PM - 3:00 PM US ET
Tuesday, October 21, 2025
2:10 PM - 2:35 PM US ET